SOLIGENIX, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
SOLIGENIX, INC. (SNGX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $512.77 thousand as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2018-03-15
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $512.77K.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $407.52K.
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $773.20K.
- 2014-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.01M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2017-12-31 | $512.77K 10-K · filed 2018-03-15 |
| 2016-12-31 | $407.52K 10-K · filed 2017-03-27 |
| 2015-12-31 | $773.20K 10-K · filed 2016-03-24 |
| 2014-12-31 | $1.01M 10-K · filed 2015-03-25 |
| 2013-12-31 | $732.00K 10-K · filed 2014-03-26 |
| 2012-12-31 | $245.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |